Institutional investors purchased a net $104.8 thousand shares of PBMD during the quarter ended June 2016, and now own 0.18% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
G1 EXECUTION SERVICES LLC Bought 15.8 Thousand shares of Prima BioMed Ltd
KCG AMERICAS LLC Bought 14.4 Thousand shares of Prima BioMed Ltd
CITADEL ADVISORS LLC Bought 7.6 Thousand shares of Prima BioMed Ltd